Duncan McHale, M.B.B.S.

2018

In 2018, Duncan McHale, M.B.B.S. earned a total compensation of $2.3M as Chief Medical Officer at Evelo Biosciences, a 171% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$161,280
Option Awards$1,737,874
Salary$371,242
Other$20,105
Total$2,290,501

MBBS received $1.7M in option awards, accounting for 76% of the total pay in 2018.

MBBS also received $161.3K in non-equity incentive plan, $371.2K in salary and $20.1K in other compensation.

Rankings

In 2018, Duncan McHale, M.B.B.S.'s compensation ranked 5,042nd out of 14,244 executives tracked by ExecPay. In other words, MBBS earned more than 64.6% of executives.

ClassificationRankingPercentile
All
5,042
out of 14,244
65th
Division
Manufacturing
1,896
out of 5,765
67th
Major group
Chemicals And Allied Products
695
out of 2,128
67th
Industry group
Drugs
581
out of 1,817
68th
Industry
Pharmaceutical Preparations
447
out of 1,391
68th
Source: SEC filing on April 25, 2019.

MBBS' colleagues

We found two more compensation records of executives who worked with Duncan McHale, M.B.B.S. at Evelo Biosciences in 2018.

2018

Balkrishan Gill

Evelo Biosciences

Chief Executive Officer

2018

Jonathan Poole

Evelo Biosciences

Chief Financial Officer

News

In-depth

You may also like